A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer

Gastric Cancer

Volumn 15, Issue SUPPL.1, 2012, Pages

  Seevaratnam, Rajini ^a   Coburn, Natalie ^a,b   Cardoso, Roberta ^a   Dixon, Matthew ^a,d   Bocicariu, Alina ^a   Helyer, Lucy ^c  

^a Institute of Clinical Evaluative Sciences   (Canada)

^b DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

^d MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

CDH1 screening; Clinical management; Genetic testing; Hereditary diffuse gastric cancer; Prophylactic gastrectomy

Indexed keywords

UVOMORULIN; CADHERIN;

AGE DISTRIBUTION; AUTOSOMAL DOMINANT INHERITANCE; BREAST CANCER; CDH1 GENE; COLON CANCER; FAMILIAL CANCER; FAMILY HISTORY; GASTRECTOMY; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; HEREDITARY DIFFUSE GASTRIC CANCER; HISTOPATHOLOGY; HUMAN; OUTCOME ASSESSMENT; PENETRANCE; PRIORITY JOURNAL; REVIEW; SIGNET RING CARCINOMA; STOMACH CANCER; SYSTEMATIC REVIEW; TREATMENT INDICATION; GENETICS; METHODOLOGY; MUTATION; STOMACH TUMOR;

CADHERINS; GASTRECTOMY; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; STOMACH NEOPLASMS;

EID: 84873415355     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-011-0116-3     Document Type: Review

References (77)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
2. Oliveira C, Seruca R, Carneiro F. Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol. 2006;14(1):21-33.
3. Caldas C, Carneiro F, Lynch HT, Yokota J, Wiesner GL, Powell SM, et al. Familial gastric cancer: overview and guidelines for management. J Med Genet. 1999;36(12):873-80.
4. Fitzgerald RC, Hardwick R, Huntsman D, Carneiro F, Guilford P, Blair V, et al. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet. 2010;47(7):436-44.
5. Oliveira C, Seruca R, Carneiro F. Hereditary gastric cancer. Best Pract Res. 2009;23(2):147-57.
6. Guilford P, Humar B, Blair V. Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice. Gastric Cancer. 2010;13(1):1-10.
7. Suriano G, Ferreira P, Mateus AR, Correia J, Henriques L, Seruca R. Genetics of hereditary diffuse gastric cancer: progress and future challenges. Future Oncol. 2006;2(3):363-70.
8. Cisco RM, Norton JA. Hereditary diffuse gastric cancer: surgery, surveillance and unanswered questions. Future Oncol. 2008;4(4):553-9.
9. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, et al. E-cadherin germline mutations in familial gastric cancer. Nature. 1998;392(6674):402-5.
10. Guilford PJ, Hopkins JB, Grady WM, Markowitz SD, Willis J, Lynch H, et al. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat. 1999;14(3):249-55.
11. Blair V, Martin I, Shaw D, Winship I, Kerr D, Arnold J, et al. Hereditary diffuse gastric cancer: diagnosis and management. Clin Gastroenterol Hepatol. 2006;4(3):262-75.
12. Hebbard PC, Macmillan A, Huntsman D, Kaurah P, Carneiro F, Wen X, et al. Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients. Ann Surg Oncol. 2009;16(7):1890-5.
13. Kaurah P, MacMillan A, Boyd N, Senz J, De Luca A, Chun N, et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA. 2007;297(21):2360-72.
14. Pharoah PD, Guilford P, Caldas C. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology. 2001;121(6):1348-53.
15. Brooks-Wilson AR, Kaurah P, Suriano G, Leach S, Senz J, Grehan N, et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet. 2004;41(7):508-17.
16. Cisco RM, Ford JM, Norton JA. Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery. Cancer. 2008;113(7 Suppl):1850-6.
17. Lynch HT, Silva E, Wirtzfeld D, Hebbard P, Lynch J, Huntsman DG. Hereditary diffuse gastric cancer: prophylactic surgical oncology implications. Surg Clin N Am. 2008;88(4):759-78. vi-vii.
18. Fitzgerald RC, Caldas C. Familial gastric cancer - clinical management. Best Pract Res. 2006;20(4):735-43.
19. Chung DC, Yoon SS, Lauwers GY, Patel D. Case records of the Massachusetts General Hospital. Case 22-2007. A woman with a family history of gastric and breast cancer. N Engl J Med. 2007;357(3):283-91.
20. Concolino P, Papa V, Mozzetti S, Ferlini C, Pacelli F, Martinelli E, et al. The unsolved enigma of CDH1 down-regulation in hereditary diffuse gastric cancer. J Surg Res. 2004;121(1):50-5.
21. Dussaulx-Garin L, Blayau M, Pagenault M, Le Berre-Heresbach N, Raoul JL, Campion JP, et al. A new mutation of E-cadherin gene in familial gastric linitis plastica cancer with extra-digestive dissemination. Eur J Gastroenterol Hepatol. 2001;13(6):711-5.
22. Fenton G. Hereditary diffuse gastric cancer: case history. Cancer Forum. 2007;31(3):162-5.
23. Francis WP, Rodrigues DM, Perez NE, Lonardo F, Weaver D, Webber JD. Prophylactic laparoscopic-assisted total gastrectomy for hereditary diffuse gastric cancer. JSLS. 2007;11(1):142-7.
24. Gayther SA, Gorringe KL, Ramus SJ, Huntsman D, Roviello F, Grehan N, et al. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res. 1998;58(18):4086-9.
25. Humar B, Toro T, Graziano F, Muller H, Dobbie Z, Kwang-Yang H, et al. Novel germline CDH1 mutations in hereditary diffuse gastric cancer families. Hum Mutat. 2002;19(5):518-25.
26. Huntsman DG, Carneiro F, Lewis FR, MacLeod PM, Hayashi A, Monaghan KG, et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med. 2001;344(25):1904-9.
27. Iida S, Akiyama Y, Ichikawa W, Yamashita T, Nomizu T, Nihei Z, et al. Infrequent germ-line mutation of the E-cadherin gene in Japanese familial gastric cancer kindreds. Clin Cancer Res. 1999;5(6):1445-7.
28. Ikonen T, Matikainen M, Mononen N, Hyytinen ER, Helin HJ, Tommola S, et al. Association of E-cadherin germ-line alterations with prostate cancer. Clin Cancer Res. 2001;7(11):3465-71.
29. Jonsson BA, Bergh A, Stattin P, Emmanuelsson M, Gronberg H. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer. Int J Cancer. 2002;98(6):838-43.
30. Keller G, Vogelsang H, Becker I, Hutter J, Ott K, Candidus S, et al. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol. 1999;155(2):337-42.
31. Kim HC, Wheeler JM, Kim JC, Ilyas M, Beck NE, Kim BS, et al. The E-cadherin gene (CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea. Gut. 2000;47(2):262-7.
32. Kusano M, Kakiuchi H, Mihara M, Itoh F, Adachi Y, Ohara M, et al. Absence of microsatellite instability and germline mutations of E-cadherin, APC and p53 genes in Japanese familial gastric cancer. Tumour Biol. 2001;22(4):262-8.
33. Lynch HT, Grady W, Lynch JF, Tsuchiya KD, Wiesner G, Markowitz SD. E-cadherin mutation-based genetic counseling and hereditary diffuse gastric carcinoma. Cancer Genet Cytogenet. 2000; 122(1):1-6.
34. Lynch HT, Kaurah P, Wirtzfeld D, Rubinstein WS, Weissman S, Lynch JF, et al. Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy. Cancer. 2008;112(12):2655-63.
35. Moran CJ, Joyce M, McAnena OJ. CDH1 associated gastric cancer: a report of a family and review of the literature. Eur J Surg Oncol. 2005;31(3):259-64.
36. More H, Humar B, Weber W, Ward R, Christian A, Lintott C, et al. Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene. Hum Mutat. 2007;28(2):203.
37. Newman EA, Mulholland MW. Prophylactic gastrectomy for hereditary diffuse gastric cancer syndrome. J Am Coll Surg. 2006;202(4):612-7.
38. Oliveira C, Bordin MC, Grehan N, Huntsman D, Suriano G, Machado JC, et al. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred. Hum Mutat. 2002;19(5):510-7.
39. Oliveira C, Ferreira P, Nabais S, Campos L, Ferreira A, Cirnes L, et al. E-Cadherin (CDH1) and p53 rather than SMAD4 and caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients. Eur J Cancer. 2004;40(12):1897-903.
40. Oliveira C, Moreira H, Seruca R, de Oliveira MC, Carneiro F. Role of pathology in the identification of hereditary diffuse gastric cancer: report of a Portuguese family. Virchows Arch. 2005;446(2):181-4.
41. Oliveira C, de Bruin J, Nabais S, Ligtenberg M, Moutinho C, Nagengast FM, et al. Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour. Oncogene. 2004;23(12):2236-40.
42. Richards FM, McKee SA, Rajpar MH, Cole TR, Evans DG, Jankowski JA, et al. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet. 1999;8(4):607-10.
43. Rodriguez-Sanjuan JC, Fontalba A, Mayorga M, Bordin MC, Hyland SJ, Trugeda S, et al. A novel mutation in the E-cadherin gene in the first family with hereditary diffuse gastric cancer reported in Spain. Eur J Surg Oncol. 2006;32(10):1110-3.
44. Rogers WM, Dobo E, Norton JA, Van Dam J, Jeffrey RB, Huntsman DG, et al. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications. Am J Surg Pathol. 2008;32(6):799-809.
45. Roviello F, Corso G, Pedrazzani C, Marrelli D, De Falco G, Berardi A, et al. Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family. Eur J Surg Oncol. 2007;33(4):448-51.
46. Roviello F, Corso G, Pedrazzani C, Marrelli D, De Falco G, Suriano G, et al. High incidence of familial gastric cancer in Tuscany, a region in Italy. Oncology. 2007;72(3-4):243-7.
47. Salahshor S, Haixin L, Huo H, Kristensen VN, Loman N, Sjoberg-Margolin S, et al. Low frequency of E-cadherin alterations in familial breast cancer. Breast Cancer Res. 2001;3(3):199-207.
48. Schrader KA, Masciari S, Boyd N, Wiyrick S, Kaurah P, Senz J, et al. Hereditary diffuse gastric cancer: association with lobular breast cancer. Fam Cancer. 2008;7(1):73-82.
49. Shinmura K, Kohno T, Takahashi M, Sasaki A, Ochiai A, Guilford P, et al. Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. Carcinogenesis. 1999;20(6):1127-31.
50. Suriano G, Oliveira C, Ferreira P, Machado JC, Bordin MC, De Wever O, et al. Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Hum Mol Genet. 2003;12(5):575-82.
51. Suriano G, Yew S, Ferreira P, Senz J, Kaurah P, Ford JM, et al. Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res. 2005;11(15):5401-9.
52. Suriano G, Seixas S, Rocha J, Seruca R. A model to infer the pathogenic significance of CDH1 germline missense variants. J Mol Med (Berl). 2006;84(12):1023-31.
53. Tanis PJ, Ten Kate FJ, van Lanschot JJ. No mucosal escape of signet-ring cell carcinoma for ten years in a patient with familial aggregation of gastric cancer. J Surg Oncol. 2008;97(3):294-6.
54. Wang Y, Song JP, Ikeda M, Shinmura K, Yokota J, Sugimura H. Ile-Leu substitution (I415L) in germline E-cadherin gene (CDH1) in Japanese familial gastric cancer. Jpn J Clin Oncol. 2003;33(1):17-20.
55. Yabuta T, Shinmura K, Tani M, Yamaguchi S, Yoshimura K, Katai H, et al. E-cadherin gene variants in gastric cancer families whose probands are diagnosed with diffuse gastric cancer. Int J Cancer. 2002;101(5):434-41.
56. Yoon KA, Ku JL, Yang HK, Kim WH, Park SY, Park JG. Germline mutations of E-cadherin gene in Korean familial gastric cancer patients. J Hum Genet. 1999;44(3):177-80.
57. Zhang Y, Liu X, Fan Y, Ding J, Xu A, Zhou X, et al. Germline mutations and polymorphic variants in MMR, E-cadherin and MYH genes associated with familial gastric cancer in Jiangsu of China. Int J Cancer. 2006;119(11):2592-6.
58. Zhu ZG, Yu YY, Zhang Y, Ji J, Zhang J, Liu BY, et al. Germline mutational analysis of CDH1 and pathologic features in familial cancer syndrome with diffuse gastric cancer/breast cancer proband in a Chinese family. Eur J Surg Oncol. 2004;30(5):531-5.
59. Barber ME, Save V, Carneiro F, Dwerryhouse S, Lao-Sirieix P, Hardwick RH, et al. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk. J Pathol. 2008;216(3):286-94.
60. Carneiro F, Huntsman DG, Smyrk TC, Owen DA, Seruca R, Pharoah P, et al. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol. 2004;203(2):681-7.
61. Caron O, Schielke A, Svrcek M, Flejou JF, Garzon J, Olschwang S, et al. Usefulness of prophylactic gastrectomy in a novel large hereditary diffuse gastric cancer (HDGC) family. Am J Gastroenterol. 2008;103(8):2160-1.
62. Charlton A, Blair V, Shaw D, Parry S, Guilford P, Martin IG. Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut. 2004;53(6):814-20.
63. Chun YS, Lindor NM, Smyrk TC, Petersen BT, Burgart LJ, Guilford PJ, et al. Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated? Cancer. 2001;92(1):181-7.
64. Framp A. Diffuse gastric cancer. Gastroenterol Nurs. 2006;29(3):232-6. quiz 6-8.
65. Gaya DR, Stuart RC, McKee RF, Going JJ, Davidson R, Stanley AJ. E-cadherin mutation-associated diffuse gastric adenocarcinoma: penetrance and non-penetrance. Eur J Gastroenterol Hepatol. 2005;17(12):1425-8.
66. Gaya DR, Stuart RC, Going JJ, Stanley AJ. Hereditary diffuse gastric cancer associated with E-cadherin mutation: penetrance after all. Eur J Gastroenterol Hepatol. 2008;20(12):1249-51.
67. Lewis FR, Mellinger JD, Hayashi A, Lorelli D, Monaghan KG, Carneiro F, et al. Prophylactic total gastrectomy for familial gastric cancer. Surgery. 2001;130(4):612-7. discussion 7-9.
68. Lynch HT, Grady W, Suriano G, Huntsman D. Gastric cancer: new genetic developments. J Surg Oncol. 2005;90(3):114-33; discussion 33.
69. Medina-Franco H, Barreto-Zuniga R, Garcia-Alvarez MN. Preemptive total gastrectomy for hereditary gastric cancer. J Gastrointest Surg. 2007;11(3):314-7.
70. Mukherjee A, McGarrity T, Staveley-O'Carroll K, Ruggiero F, Baker M. Hereditary diffuse gastric cancer: lifesaving potential of prophylactic gastrectomy. Community Oncol. 2009;6(1):41-5.
71. Norton JA, Ham CM, Van Dam J, Jeffrey RB, Longacre TA, Huntsman DG, et al. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Ann Surg. 2007;245(6):873-9.
72. Shaw D, Blair V, Framp A, Harawira P, McLeod M, Guilford P, et al. Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy? Gut. 2005;54(4):461-8.
73. van Kouwen MC, Drenth JP, Oyen WJ, de Bruin JH, Ligtenberg MJ, Bonenkamp JJ, et al. [18F]Fluoro-2-deoxy-d-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic E-cadherin mutation carrier. Clin Cancer Res. 2004;10(19):6456-9.
74. Oelschlager BK, Yigit T, Kaufman JA, Pellegrini CA. Hereditary diffuse gastric cancer. Med Gen Med. 2005;7(3):16.
75. Grady WM, Willis J, Guilford PJ, et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet. 2000;26:16-7.
76. Machado JC, Oliveira C, Carvalho R, et al. E-cadherin gene (CDH1) promoter methylation as the 2nd hit in sporadic diffuse gastric carcinoma. Oncogene. 2001;20:1525-8.
77. Kaurah P, Fitzgerald R, Dwerryhouse S, Huntsman DG. Pregnancy after prophylactic total gastrectomy. Fam Cancer. 2010;9(3):331-4.